Recent Science press releases & news

[PRESSWIRE] Dublin, Ireland - 09 December, 2019 -- Workvivo will Provide Employee Engagement App. Irish employee engagement firm Workvivo has teamed up with US-based Seneca Gaming Corporation.

[PRESSWIRE] France - 08 11 2019 -– In what represents a major milestone on the path to clinical application, a novel method to improve outcomes of Epilepsy surgery has now received approval for clinical testing in 13 French hospitals. The approach could provide a better therapeutic perspective against the drug-resistant form of the disease, which constitutes one third of all cases, and is a development by Human Brain Project scientist Viktor Jirsa and an interdisciplinary team of collaborators. To help clinicians plan surgery strategies, the scientists create personalized brain models of patients and simulate the spread of abnormal activity during epileptic seizures. The method represents the first example of a personalized brain modeling approach entering the clinic and will now be assessed over four years in a cohort of 356 patients under strict requirements.

[PRESSWIRE] Sochi, Russia - 24 October, 2019 -- The Synthestech Company, has the pleasure to invite the international press and its members to a press conference entitled: A big step in the fight against aging.

[PRESSWIRE] Squamish, B.C. - September 17, 2019 -- Canadian clean energy company, Carbon Engineering Ltd. (CE), today announced it is expanding the capacity of the design for its first commercial Direct Air Capture (DAC) plant, to enable corporate customers to permanently remove carbon dioxide (CO2) emissions from the atmosphere. 

[PRESSWIRE] Budapest - June 13, 2019 -- High cardiovascular morbidity and mortality remain a persisting problem in patients with CKD. Many efforts have been made in subjects with normal kidney function to prevent and to reduce the progression of cardiovascular diseases.

[PRESSWIRE] Budapest - June 13, 2019 -- Alport syndrome (AS) is a hereditary type IV collagen disease that leads to progressive proteinuria, renal fibrosis, and kidney failure.

[PRESSWIRE] Parma - April 26, 2019 -- The recently published CREDENCE study [1] showed that SGLT2 inhibitors can slow progression of chronic kidney disease (CKD) in diabetes patients in addition to the effects seen with RAAS blockade. The study results were presented at the World Nephrology Congress in Melbourne and showed that Canagliflozin was associated with a 34% risk reduction of the renal end point (end stage renal disease, doubling of serum creatinine or renal death). The previous day, the SONAR study had shown that the selective endothelin A receptor antagonist, atrasentan, reduced the risk of renal events in a specially selected CKD cohort with diabetes to a similar extent (35%).

[PRESSWIRE] Parma - 05 March, 2019 --  “Kidney health for everyone everywhere” – ERA-EDTA has helped to put this motto into practice by offering support for young nephrologists living in disadvantage areas.

[PRESSWIRE] Parma - 05 March, 2019 -- 850 million people worldwide are affected by kidney disease [1] – a worrying figure, and one that continues to rise. Prevention of chronic kidney disease is therefore more important than ever, as Professor Carmine Zoccali (Reggio Calabria, Italy), President of the ERA-EDTA, emphasizes on the occasion of World Kidney Day on March 14, 2019.

[PRESSWIRE] Parma - January 22, 2019 -- 16% of the patients on renal replacement therapy are under the age of 40. These younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.